Compare CWD & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CWD | HKPD |
|---|---|---|
| Founded | 2009 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Real Estate | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3M | 5.5M |
| IPO Year | 2022 | 2024 |
| Metric | CWD | HKPD |
|---|---|---|
| Price | $0.44 | $0.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 5.1M | 422.9K |
| Earning Date | 11-12-2026 | 08-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $20,097,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.16 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.43 | $0.10 |
| 52 Week High | $3.75 | $1.68 |
| Indicator | CWD | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 36.69 | 34.43 |
| Support Level | N/A | $0.10 |
| Resistance Level | $0.60 | $0.70 |
| Average True Range (ATR) | 0.05 | 0.01 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 2.08 | 65.79 |
CaliberCos Inc is an asset management firm investing across real and digital assets. It sponsors and manages private real estate investment funds and maintains a digital asset treasury approach focused on blockchain infrastructure assets. The company's activities are supported by transaction and advisory services, including development and construction management, acquisition and disposition services, brokerage, and fund formation services. The company operates through one reportable segment. It generates the majority of its revenue in the form of asset management fee revenues and performance allocations.
Cellyan Biotechnology Co Ltd is an integrated pharmaceutical cross-border e-commerce supply chain service provider with a professional team and related pharmaceutical storage facilities in Hong Kong. It operates through two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, referred to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, referred to as the Procurement and Distribution division. Its main business provides one-stop services for merchants engaged in cross-border pharmaceutical e-commerce, including OTC wholesale, import and export, warehousing, packaging, customs clearance and delivery to final destinations, forming a closed loop of pharmaceutical cross-border e-commerce supply chain.